Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Search Results

Refine Your Search

By Sector

Sort by: Date|Relevance

Nextech CEO provides company update on Amazon deal and more

The following is a transcription of the above video, and The Market Online has edited it for clarity . Nextech3D.ai (CSE:NTAR) is rapidly making gains via its proprietary artificial intelligence that creates 3D models and is being utilized in major e-commerce setti...

AI as a winning model!

200% return with Super Micro Computer and BlockchainK2; caution with Intel and Aixtron! The high-tech wave has been quite pronounced so far in 2024. Even the correction in July had little impact on the strong trend, which is now continuing upward. However, inve...

Can NervGen keep a lid on explosive news?

Speculation of early “evidence” of successful proof-of-concept human trials sparks stock rallies Trial volunteers taking a placebo are offered the real deal in a follow-up trial as a “reward” The company&Clo...

Is this stunning 'evidence' that NervGen has the goods?

This could be the signal that tiny NervGen Pharma Corp. (TSX-V:NGEN; OTCQX:NGENF) is destined to be one of the top performing biotech startup stocks this year. It came in a seemingly innocuous podcast interview about the company’s ongoing Phase 1b/2...

Medicus Pharma advances cancer treatment towards phase II trial

The following is a transcription of the above video, and The Market Herald Canada has edited it for clarity . Our next company is Medicus Pharma Ltd. (TSXV:MDCX) , headquartered in Philadelphia, Pennsylvania. The company is a publicly traded clinical stage, multi-st...

Is Canopy Growth a good stock to buy?

Canopy Growth Corp. (TSX:WEED) holds a prominent position in the Canadian cannabis industry, but is it a good stock to buy? Initially, the stock experienced remarkable growth, driven by the anticipation surrounding the legalization of recreational cannabis in ...

Buzz on the Bullboards: More stocks to be thankful for

Despite current market tensions, what are investors thankful for? Even if the U.S. Thanksgiving is something you don’t celebrate, the recent rally among major stock markets could be some cause for celebration. But this rising market tide isn&CloseCurly...

ExoTherapy offers hope for treating acute spinal cord injuries

Suffering from traumatic injuries can leave a person with long-term damages and/or side effects that are hard to navigate long after the initial incident has passed. Our next company is a publicly traded bio-pharmaceutical company, working on the development of its ...

Buzz on the Bullboards: The calm before another September rally?

It’s the last leg of what looks like an end-of-month rally as investors try to make the most of August’s losses. Traders are neck-deep into a data-heavy week from company fiscal reports that could chart the hike path for interest rates. ...

Bocana Resources advancing precious metals project in "favorable" Bolivian jurisdiction

Headquartered in Calgary, Bocana Resources is focused on exploring and developing precious metals assets in South America. Its primary focus rests on the Escala concession, located in the Sud Lipez Province in Southwestern Bolivia. Bocana Resources Chief Executive...
1 2 3 4 5 6 7 8 9 10 ...
USER FEEDBACK SURVEY ×

Be the voice that helps shape the content on site!

At Stockhouse, we’re committed to delivering content that matters to you. Your insights are key in shaping our strategy. Take a few minutes to share your feedback and help influence what you see on our site!

The Market Online in partnership with Stockhouse